大剂量他汀类药物对冠心病合并肾功能不全患者肾功能、血管内皮功能及炎症因子水平的影响

Ai-jie Hou, Wen-guang Li, H. Xue
{"title":"大剂量他汀类药物对冠心病合并肾功能不全患者肾功能、血管内皮功能及炎症因子水平的影响","authors":"Ai-jie Hou, Wen-guang Li, H. Xue","doi":"10.3760/CMA.J.ISSN.1674-4756.2020.05.031","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the effects of large dose of rosuvastatin on renal function, vascular endothelial function and levels of inflammatory factor in patients with coronary heart disease complicated with renal insufficiency. \n \n \nMethods \nSixty patients with coronary heart disease complicated with renal insufficiency admitted to the Second People’s Hospital from January 2015 to December 2018 were randomly divided into the control group and study group by random number table method, with 30 patients in each group. Patients in the control group were treated with conventional dose of rosuvastatin, and patients in the study group were treated with large dose of rosuvastatin. The renal function, vascular endothelial function, levels of inflammatory factor and incidence of adverse reactions were compared between the two groups. \n \n \nResults \nThere was no significant difference in 24 h urinary protein or serum creatinine between the two groups before treatment (P>0.05); after treatment, the levels of 24 h urinary protein and serum creatinie decreased in both groups, and the study group had higher 24 h urinary protein level than the control group (P 0.05). After treatment, Hcy levels decreased, but NO and eNOS levels increased in both groups; compared to control group, and the Hcy levels in the study group were lower, while NO and eNOS levels were higher (P 0.05). The incidence of adverse reaction of the study group was 33.33% (10/30), higher than the 26.67% (8/30) of the control group, but there was no significant difference in incidence of adverse reactions between the two groups (P>0.05). \n \n \nConclusions \nLarge dose of rosuvastatin in the treatment of patients with coronary heart disease and renal insufficiency can significantly improve renal function and vascular endothelial function, and reduce inflammation levels, without increasing incidence of adverse reactions. \n \n \nKey words: \nLarge dose; Statins; Coronary heart disease; Renal insufficiency; Renal function; Vascular endothelial function; Inflammatory factors","PeriodicalId":9667,"journal":{"name":"Central Plains Medical Journal","volume":"85 1","pages":"103-105"},"PeriodicalIF":0.0000,"publicationDate":"2020-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effects of large dose of statins on renal function, vascular endothelial function and levels of inflammatory factor in patients with coronary heart disease complicated with renal insufficiency\",\"authors\":\"Ai-jie Hou, Wen-guang Li, H. Xue\",\"doi\":\"10.3760/CMA.J.ISSN.1674-4756.2020.05.031\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective \\nTo analyze the effects of large dose of rosuvastatin on renal function, vascular endothelial function and levels of inflammatory factor in patients with coronary heart disease complicated with renal insufficiency. \\n \\n \\nMethods \\nSixty patients with coronary heart disease complicated with renal insufficiency admitted to the Second People’s Hospital from January 2015 to December 2018 were randomly divided into the control group and study group by random number table method, with 30 patients in each group. Patients in the control group were treated with conventional dose of rosuvastatin, and patients in the study group were treated with large dose of rosuvastatin. The renal function, vascular endothelial function, levels of inflammatory factor and incidence of adverse reactions were compared between the two groups. \\n \\n \\nResults \\nThere was no significant difference in 24 h urinary protein or serum creatinine between the two groups before treatment (P>0.05); after treatment, the levels of 24 h urinary protein and serum creatinie decreased in both groups, and the study group had higher 24 h urinary protein level than the control group (P 0.05). After treatment, Hcy levels decreased, but NO and eNOS levels increased in both groups; compared to control group, and the Hcy levels in the study group were lower, while NO and eNOS levels were higher (P 0.05). The incidence of adverse reaction of the study group was 33.33% (10/30), higher than the 26.67% (8/30) of the control group, but there was no significant difference in incidence of adverse reactions between the two groups (P>0.05). \\n \\n \\nConclusions \\nLarge dose of rosuvastatin in the treatment of patients with coronary heart disease and renal insufficiency can significantly improve renal function and vascular endothelial function, and reduce inflammation levels, without increasing incidence of adverse reactions. \\n \\n \\nKey words: \\nLarge dose; Statins; Coronary heart disease; Renal insufficiency; Renal function; Vascular endothelial function; Inflammatory factors\",\"PeriodicalId\":9667,\"journal\":{\"name\":\"Central Plains Medical Journal\",\"volume\":\"85 1\",\"pages\":\"103-105\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-03-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Central Plains Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1674-4756.2020.05.031\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Central Plains Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1674-4756.2020.05.031","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

目的分析大剂量瑞舒伐他汀对冠心病合并肾功能不全患者肾功能、血管内皮功能及炎症因子水平的影响。方法选取2015年1月~ 2018年12月第二人民医院收治的冠心病合并肾功能不全患者60例,采用随机数字表法随机分为对照组和研究组,每组30例。对照组给予常规剂量瑞舒伐他汀治疗,研究组给予大剂量瑞舒伐他汀治疗。比较两组患者肾功能、血管内皮功能、炎症因子水平及不良反应发生率。结果两组患者治疗前24 h尿蛋白、血清肌酐比较,差异均无统计学意义(P>0.05);治疗后,两组患者24 h尿蛋白水平和血清肌酐水平均下降,且研究组患者24 h尿蛋白水平高于对照组(P < 0.05)。治疗后,两组患者Hcy水平下降,NO、eNOS水平升高;研究组患者Hcy水平低于对照组,NO、eNOS水平高于对照组(P < 0.05)。研究组不良反应发生率为33.33%(10/30),高于对照组的26.67%(8/30),但两组不良反应发生率比较差异无统计学意义(P>0.05)。结论大剂量瑞舒伐他汀治疗冠心病合并肾功能不全患者可显著改善肾功能和血管内皮功能,降低炎症水平,且不增加不良反应的发生率。关键词:大剂量;他汀类药物;冠心病;肾功能不全;肾功能;血管内皮功能;炎症因子
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Effects of large dose of statins on renal function, vascular endothelial function and levels of inflammatory factor in patients with coronary heart disease complicated with renal insufficiency
Objective To analyze the effects of large dose of rosuvastatin on renal function, vascular endothelial function and levels of inflammatory factor in patients with coronary heart disease complicated with renal insufficiency. Methods Sixty patients with coronary heart disease complicated with renal insufficiency admitted to the Second People’s Hospital from January 2015 to December 2018 were randomly divided into the control group and study group by random number table method, with 30 patients in each group. Patients in the control group were treated with conventional dose of rosuvastatin, and patients in the study group were treated with large dose of rosuvastatin. The renal function, vascular endothelial function, levels of inflammatory factor and incidence of adverse reactions were compared between the two groups. Results There was no significant difference in 24 h urinary protein or serum creatinine between the two groups before treatment (P>0.05); after treatment, the levels of 24 h urinary protein and serum creatinie decreased in both groups, and the study group had higher 24 h urinary protein level than the control group (P 0.05). After treatment, Hcy levels decreased, but NO and eNOS levels increased in both groups; compared to control group, and the Hcy levels in the study group were lower, while NO and eNOS levels were higher (P 0.05). The incidence of adverse reaction of the study group was 33.33% (10/30), higher than the 26.67% (8/30) of the control group, but there was no significant difference in incidence of adverse reactions between the two groups (P>0.05). Conclusions Large dose of rosuvastatin in the treatment of patients with coronary heart disease and renal insufficiency can significantly improve renal function and vascular endothelial function, and reduce inflammation levels, without increasing incidence of adverse reactions. Key words: Large dose; Statins; Coronary heart disease; Renal insufficiency; Renal function; Vascular endothelial function; Inflammatory factors
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信